Volume 17, Issue 4 (April 2019 2019)                   IJRM 2019, 17(4): 271-278 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghomian N, Vakilian F, Shahri B, Rostaminejad V, Khadem-Rezaiyan M. Can brain natriuretic peptide predict cardiovascular complications in severe preeclampsia? A case-control study. IJRM 2019; 17 (4) :271-278
URL: http://ijrm.ir/article-1-1494-en.html
1- Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2- Department of Cardiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3- Department of Social Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran , majidrezaiyan@yahoo.com
Abstract:   (2663 Views)
Background: Preeclampsia is one of the most common pregnancy complications, which is one of the major causes of fetal and maternal mortality.
Objective: To compare the serum Brain Natriuretic Peptide (BNP) level in patients with severe preeclampsia and normal pregnancy and investigate associated cardiovascular complications.
Materials and Methods: This case-control study was performed on 94 women with a singleton pregnancy (severe preeclampsia and normal pregnancy) at Imam Reza Hospital in Mashhad, Iran. The venous blood samples were collected to evaluate the serum BNP level. All patients were subjected to echocardiography performed by a single cardiologist.
Results: The mean pro-BNP levels were 480.36 ± 754.52 and 67.46 ± 106.24 pg/dL in the severe preeclampsia and normal pregnancy patients, respectively (p < 0.001). However, adjusted BNP for maternal and gestational age was not different in the two groups (ANCOVA, p = 0.69). Furthermore, the two study groups showed no significant difference in terms of the cardiac parameters, including ejection fraction (EF), left ventricle end-diastolic and -systolic diameters (LVEDD and LVESD, respectively), tricuspid annular plane systolic excursion (TAPSE), and ratio of the early transmitral flow velocity to the early diastolic tissue velocity (E/Em). However, the serum BNP level showed a significant correlation with EF (r = -0.39, p = 0.008), TAPSE (r = -0.47, p = 0.001), and E/Em ratio (r = 0.48, p = 0.001) in patients with severe preeclampsia.
Conclusion: It seems that BNP can be used as a predictor for some of the main cardiac functional indices (i.e., E/Em, EF, and TAPSE) in severe preeclampsia patients.
Full-Text [PDF 414 kb]   (706 Downloads) |   |   Full-Text (HTML)  (455 Views)  
Type of Study: Original Article |

References
1. [1] Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-1074. [DOI:10.1016/S0140-6736(06)68397-9]
2. [2] Saucedo M, Deneux-Tharaux C, Bouvier-Colle MH, French National Experts Committee on Maternal Mortality. Ten years of confidential inquiries into maternal deaths in France, 1998-2007. Obstet Gynecol 2013; 122: 752-760. [DOI:10.1097/AOG.0b013e31829fc38c]
3. [3] Fatemeh T, Marziyeh G, Nayereh G, Anahita G, Samira T. Maternal and perinatal outcome in nulliparious women complicated with pregnancy hypertension. J Pak Med Assoc 2010; 60: 707-710.
4. [4] Creanga AA, Syverson C, Seed K, Callaghan WM. Pregnancy-related mortality in the United States, 2011- 2013. Obstet Gynecol 2017; 130: 366-373. [DOI:10.1097/AOG.0000000000002114]
5. [5] Walker JJ. Pre-eclampsia. Lancet 2000; 356: 1260-1265. [DOI:10.1016/S0140-6736(00)02800-2]
6. [6] Novelli GP, Valensise H, Vasapollo B, Larciprete G, Di Pierro G, Altomare F, et al. Are gestational and essential hypertension similar? Left ventricular geometry and diastolic function. Hypertens Pregnancy 2003; 22: 225-237. [DOI:10.1081/PRG-120024026]
7. [7] Simmons LA, Gillin AG, Jeremy RW. Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 2002; 283: H1627-H1633. [DOI:10.1152/ajpheart.00966.2001]
8. [8] Sibai BM, Habli M. Hypertensin disease of pregnancy. In: Gibbs R, Karlan BY, Hanay SF, Nygard I. Danforth' Sobsetetrics & Gynecology. 10th ed. Lippencat & Willksins; USA: 2008. p.258-359.
9. [9] James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy. Circulation 2003; 108: 275-281. [DOI:10.1161/01.CIR.0000079170.10579.DC]
10. [10] Fazlinezhad A, Rezaeian MK, Yousefzadeh H, Ghaffarzadegan K, Khajedaluee M. Plasma brain natriuretic peptide (BNP) as an indicator of left ventricular function, early outcome and mechanical complications after acute myocardial infarction. Clin Med Insights Cardiol 2011; 5: 77-83. [DOI:10.4137/CMC.S7189]
11. [11] Afshani N, Moustaqim-Barrette A, Biccard BM, Rodseth RN, Dyer RA. Utility of B-type natriuretic peptides in preeclampsia: a systematic review. Int J Obstet Anesth 2013; 22: 96-103. [DOI:10.1016/j.ijoa.2012.11.001]
12. [12] Raflic Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclapsia by echocardiography and cardiovascular biomarkers. J Hypertens 2009; 27: 2257-2264. [DOI:10.1097/HJH.0b013e3283300541]
13. [13] Rafik Hamad R, Larsson A, Pernow J, Bremme K, Eriksson MJ. Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers. J Hypertension 2009; 27: 2257-2264. [DOI:10.1097/HJH.0b013e3283300541]
14. [14] American college of obstetricians and gynecologists; task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the american college of obstetricians and gynecologists' task force on hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122-1131.
15. [15] Resnik JL, Hong C, Resnik R, Kazanegra R, Beede J, Bhalla V, et al. Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. Am J Obstet Gynecol 2005; 193: 450-454. [DOI:10.1016/j.ajog.2004.12.006]
16. [16] Bakacak M, Serin S, Ercan O, Köstü B, Bakacak Z, Kiran H. Association of serum N-terminal pro-brain natriuretic peptide levels with the severity of preeclampsia. J Maternal Fetal Neonat Med 2016; 29: 2802-2806. [DOI:10.3109/14767058.2015.1104663]
17. [17] Fayers S, Moodley J, Naidoo DP. Cardiovascular haemodynamics in pre-eclampsia using brain naturetic peptide and tissue Doppler studies. Cardiovasc J Afr 2013; 24: 130-136. [DOI:10.5830/CVJA-2013-023]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb